Chemoinformaics analysis of arteannuic acid alcohol
| Molecular Weight | 234.339 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
| Exact Molecular Weight | 234.162 | nRing | 2 |
| Solubility: LogS | -3.1 | nHRing | 0 |
| Solubility: LogP | 4.369 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.3234 |
| nHD | 1 | BPOL | 22.9386 |
| QED | 0.585 |
| Synth | 4.255 |
| Natural Product Likeliness | 2.744 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.104 |
| CACO-2 | -4.685 |
| MDCK | 0.0000136 |
| BBB | 0.072 |
| PPB | 0.961513 |
| VDSS | 0.423 |
| FU | 0.0393809 |
| CYP1A2-inh | 0.261 |
| CYP1A2-sub | 0.37 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.595 |
| CYP2c9-inh | 0.369 |
| CYP2c9-sub | 0.376 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.221 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.199 |
| CL | 2.5 |
| T12 | 0.682 |
| hERG | 0.031 |
| Ames | 0.014 |
| ROA | 0.947 |
| SkinSen | 0.636 |
| Carcinogencity | 0.678 |
| EI | 0.855 |
| Respiratory | 0.961 |
| NR-Aromatase | 0.496 |
| Antiviral | Yes |
| Prediction | 0.919511 |